Point72 Hong Kong’s Neuronetics STIM Stock Holding History

Point72 Hong Kong’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-593	Closed	-$4K	–	2362
2021 Q3	$4K	Buy	+593	New	+$5.69K	﹤0.01%	1857

Other funds holding STIM

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Point72 Hong Kong's STIM Position: Q4 2021 in Review

Point72 Hong Kong sold out of Neuronetics (STIM) in Q4 2021, closing a stake of 593 shares — an estimated $4K sold.

Point72 Hong Kong first reported a position in STIM in Q3 2021 and held it in 1 quarter. The position peaked at $4K in Q3 2021. 80 funds tracked by Wall St. Rank hold STIM as of Q4 2021.

Point72 Hong Kong reported no remaining Neuronetics position as of Q4 2021 after selling out during the quarter.
Point72 Hong Kong sold 593 Neuronetics shares in Q4 2021, an estimated $4K.
Point72 Hong Kong first reported a position in Neuronetics in Q3 2021 and held it in 1 quarter.
Point72 Hong Kong's Neuronetics position peaked at $4K in Q3 2021.
80 funds tracked by Wall St. Rank held Neuronetics as of Q4 2021.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.